Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy [Phase 2]
A Phase 2 trial evaluated celecoxib for age-related macular degeneration in patients receiving photodynamic therapy; the study has completed…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Diabetic Retinopathy and Visual Function Study
The clinical trial investigating Diabetic Retinopathy and Macular Degeneration has completed. Sponsored by the National Eye Institute (NEI).
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration [Phase 1]
Phase I clinical trial evaluating corticosteroid treatment for ill-defined choroidal neovascularization in age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Fluocinolone Implant to Treat Macular Degeneration [Phase 1]
An NEI-sponsored Phase 1 trial evaluating a fluocinolone implant for macular degeneration (including choroidal neovascularization) has compl…
-
CLINICAL_TRIALS research · 2008-03-03Clinical Trial Update: Assessment of Macular Edema Using HRT Technique [NA]
This entry reports a clinical trial evaluating macular edema assessment using the HRT technique in Age-Related Macular Degeneration; trial s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
A completed clinical trial update evaluating the PHP Home Preferential Hyperacuity Perimeter for detecting choroidal neovascularization in A…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
Clinical trial update on the PreView PHP device, which uses preferential hyperacuity perimeter testing to detect choroidal neovascularizatio…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: Retaane® in Age-Related Macular Degeneration [Phase 2, Phase 3]
Retaane has completed Phase 2 and Phase 3 trials for age-related macular degeneration, according to a ClinicalTrials.gov update. The status …
-
CLINICAL_TRIALS research · 2007-12-05Clinical Trial Update: Stratus Versus Cirrus OCT in AMD
Clinical trial update comparing Stratus versus Cirrus OCT devices for age-related macular degeneration and choroidal neovascularization.
-
CLINICAL_TRIALS trial_result · 2007-11-28Clinical Trial Update: A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration [Phase 3]
Phase 3 safety and efficacy trial of Squalamine lactate for injection (MSI-1256F) for wet age-related macular degeneration has been terminat…
-
CLINICAL_TRIALS trial_result · 2007-11-28Clinical Trial Update: A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration [Phase 2]
Phase 2 safety and efficacy study of MSI-1256F (squalamine lactate) for wet age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-28Clinical Trial Update: A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration [Phase 2]
A Phase 2 study of MSI-1256F (squalamine lactate) for wet age-related macular degeneration was terminated.
-
CLINICAL_TRIALS withdrawal · 2007-11-07Clinical Trial Update: Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis [Phase 3]
A Phase 3 trial evaluating rheopheresis for dry, non-exudative age-related macular degeneration has been suspended.
-
CLINICAL_TRIALS research · 2007-09-21Clinical Trial Update: Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population [NA]
A clinical trial update examining whether the Y402H variant in Complement Factor H is associated with age-related macular degeneration in pe…
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers [Phase 1]
This update notes the completion of a Phase 1 safety study of TG100801 Eye Drops in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is investigating Triamcinolone Acetonide as an adjunct to verteporfin photodynamic therapy for age-related …
-
CLINICAL_TRIALS trial_result · 2007-07-12Clinical Trial Update: Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration [Phase 2]
Phase 2 study evaluating the combination of Visudyne (verteporfin) with Kenalog (triamcinolone) for choroidal neovascularization due to age-…
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [Phase 2]
Phase 2 trial evaluating open-label anecortave acetate sterile suspension (15 mg) for age-related macular degeneration with subfoveal neovas…
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) [Phase 3]
Pfizer completed a Phase 3 clinical trial of EYE001 for wet age-related macular degeneration (NCT00150202). The study status is reported as …
-
CLINICAL_TRIALS research · 2007-04-27Clinical Trial Update: Copaxone in Age Related Macular Degeneration [Phase 2, Phase 3]
Copaxone (glatiramer acetate) is being evaluated in phase 2/3 trials for age-related macular degeneration, and the study status is currently…
-
CLINICAL_TRIALS research · 2007-04-27Clinical Trial Update: Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP). [Phase 2]
Phase 2 trial evaluating indocyanine green–mediated photothrombosis for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD [Phase 2]
Phase 2 study evaluating two different sequences of bevacizumab and verteporfin for neovascular age-related macular degeneration; the trial …
-
CLINICAL_TRIALS trial_result · 2007-01-15Clinical Trial Update: Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) [Phase 4]
Phase 4 trial evaluating Macugen alone versus Macugen plus PDT with Visudyne in age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2007-01-15Clinical Trial Update: A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD [Phase 4]
A Phase 4 clinical trial is being conducted to assess the safety and efficacy of pegaptanib (Macugen) injections every six weeks in people w…
-
CLINICAL_TRIALS research · 2006-09-25Clinical Trial Update: Long-Term Efficacy in AMD of Rheopheresis in North America [NA]
Clinical trial update on the long-term efficacy of rheopheresis for age-related macular degeneration in North America; sponsor OccuLogix.